{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "acute respiratory syndrome coronavirus 2",
      "cutaneous",
      "manifestations",
      "molecular",
      "skin"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32867008",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/exd.14186"
    ],
    "Journal": {
      "ISSN": "1600-0625",
      "JournalIssue": {
        "Volume": "29",
        "Issue": "10",
        "PubDate": {
          "Year": "2020",
          "Month": "Oct"
        }
      },
      "Title": "Experimental dermatology",
      "ISOAbbreviation": "Exp Dermatol"
    },
    "ArticleTitle": "Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.",
    "Pagination": {
      "StartPage": "936",
      "EndPage": "944",
      "MedlinePgn": "936-944"
    },
    "Abstract": {
      "AbstractText": [
        "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a new public health problem, with a total of 10.577.263 documented COVID-19 cases worldwide and 513.441 deaths up to the present date. Few cases of disease-related cutaneous manifestations have been reported in the literature, and such manifestations are scarce. Integumentary manifestations from COVID-19 include exanthemas and papular dermatoses, urticarial eruptions, atopic dermatitis, vesiculobullous lesions and skin signs of hypercoagulable states, such as acral ischaemia, livedo and retiform purpura. Most common extracutaneous manifestations from the disease include headache, cough, anosmia, ageusia, fever, dyspnoea, nausea, diarrhoea and cardiovascular events. The objectives of this review were to discuss the role of human cell receptors described as interaction targets of SARS-CoV-2, as well to understand the current state of knowledge on skin expression of these receptors, in order to substantiate future research. The authors present a thorough literature review on SARS-CoV-2 and its possible interaction with cell receptors and human tissues including the skin. They discuss a molecular hypothesis to explain the lower prevalence of dermatological manifestations from direct SARS-CoV-2 infection. Distinct human cell receptors binding the virus appear to be less expressed in the skin compared to other organs. Additionally, the presence of resolvins and the disintegrin metalloprotease ADAM17 provide a putative protection to the skin, explaining the majority of COVID-19 manifestations to be extracutaneous. This review represents an excellent opportunity for future studies using skin biopsies from COVID-19 patients to investigate molecular expression in the pathophysiology of cutaneous manifestations of the disease."
      ],
      "CopyrightInformation": "\u00a9 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Department, Centro Universit\u00e1rio Sa\u00fade ABC, Santo Andr\u00e9, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "LIM-50, Faculdade de Medicina da Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "Ricardo Criado",
        "ForeName": "Paulo",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0003-1722-5970"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, Mayo Clinic, Jacksonville, FL, USA."
          }
        ],
        "LastName": "Pincelli",
        "ForeName": "Thais Prota Hussein",
        "Initials": "TPH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Department, Centro Universit\u00e1rio Sa\u00fade ABC, Santo Andr\u00e9, Brazil."
          }
        ],
        "LastName": "Criado",
        "ForeName": "Roberta Fachini Jardim",
        "Initials": "RFJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Department, Centro Universit\u00e1rio Sa\u00fade ABC, Santo Andr\u00e9, Brazil."
          }
        ],
        "LastName": "Abdalla",
        "ForeName": "Beatrice Martinez Zugaib",
        "Initials": "BMZ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LIM-50, Faculdade de Medicina da Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "Belda Junior",
        "ForeName": "Walter",
        "Initials": "W"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Denmark",
    "MedlineTA": "Exp Dermatol",
    "NlmUniqueID": "9301549",
    "ISSNLinking": "0906-6705"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Virus"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "ACE2 protein, human"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    },
    {
      "RegistryNumber": "EC 3.4.21.-",
      "NameOfSubstance": "Serine Endopeptidases"
    },
    {
      "RegistryNumber": "EC 3.4.21.-",
      "NameOfSubstance": "TMPRSS2 protein, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "pathology",
        "physiopathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Host Microbial Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Biological"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Organ Specificity"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Receptors, Virus"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Serine Endopeptidases"
    },
    {
      "QualifierName": [
        "pathology",
        "physiopathology",
        "virology"
      ],
      "DescriptorName": "Skin"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Virus Activation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    }
  ]
}